BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
Number Citing Articles
1 Němec V, Khirsariya P, Janovská P, Moyano PM, Maier L, Procházková P, Kebková P, Gybel' T, Berger BT, Chaikuad A, Reinecke M, Kuster B, Knapp S, Bryja V, Paruch K. Discovery of Potent and Exquisitely Selective Inhibitors of Kinase CK1 with Tunable Isoform Selectivity. Angew Chem Int Ed Engl 2023;62:e202217532. [PMID: 36625768 DOI: 10.1002/anie.202217532] [Reference Citation Analysis]
2 Xin X, Wang Y, Zhang L, Zhang D, Sha L, Zhu Z, Huang X, Mao W, Zhang J. Development and therapeutic potential of adaptor-associated kinase 1 inhibitors in human multifaceted diseases. Eur J Med Chem 2023;248:115102. [PMID: 36640459 DOI: 10.1016/j.ejmech.2023.115102] [Reference Citation Analysis]
3 Murray NH, Asquith CRM, Fang Z, East MP, Ptak N, Smith RW, Vasta JD, Zimprich CA, Corona CR, Robers MB, Johnson GL, Bingman CA, Pagliarini DJ. Small-molecule inhibition of the archetypal UbiB protein COQ8. Nat Chem Biol 2023;19:230-8. [PMID: 36302899 DOI: 10.1038/s41589-022-01168-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Serafim RA, Haarer L, Pedreira JG, Gehringer M. Covalent chemical probes for protein kinases. Current Research in Chemical Biology 2023. [DOI: 10.1016/j.crchbi.2022.100040] [Reference Citation Analysis]
5 Zhao Z, Bourne PE. Systematic Exploration of Privileged Warheads for Covalent Kinase Drug Discovery. Pharmaceuticals 2022;15:1322. [DOI: 10.3390/ph15111322] [Reference Citation Analysis]
6 Müller CE. Call for Manuscripts for ACS Pharmacology & Translational Science Review Series on Recommended Tool Compounds. ACS Pharmacol Transl Sci . [DOI: 10.1021/acsptsci.2c00135] [Reference Citation Analysis]
7 Murray NH, Lewis A, Asquith CRM, Rincon Pabon JP, Fang Z, Ptak N, Smith RW, Vasta JD, Zimprich CA, Corona CR, Robers MB, Bingman CA, Gross ML, Henzler-wildman K, Pagliarini DJ. Small Molecule Modulation of the Archetypal UbiB protein COQ8.. [DOI: 10.1101/2022.03.22.485346] [Reference Citation Analysis]
8 M Serafim RA, da Silva Santiago A, Schwalm MP, Hu Z, Dos Reis CV, Takarada JE, Mezzomo P, Massirer KB, Kudolo M, Gerstenecker S, Chaikuad A, Zender L, Knapp S, Laufer S, Couñago RM, Gehringer M. Development of the First Covalent Monopolar Spindle Kinase 1 (MPS1/TTK) Inhibitor. J Med Chem 2022. [PMID: 35167750 DOI: 10.1021/acs.jmedchem.1c01165] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Gerstenecker S, Haarer L, Schröder M, Kudolo M, Schwalm MP, Wydra V, Serafim RAM, Chaikuad A, Knapp S, Laufer S, Gehringer M. Discovery of a Potent and Highly Isoform-Selective Inhibitor of the Neglected Ribosomal Protein S6 Kinase Beta 2 (S6K2). Cancers (Basel) 2021;13:5133. [PMID: 34680283 DOI: 10.3390/cancers13205133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]